Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
This target profile refers to a broad collective of biological entities, including microbial structural proteins, enzymes, lipids, and nucleic acids, as well as host-derived inflammatory mediators like cytokines and chemokines. Rather than interacting with a single specific receptor or enzyme pocket, therapeutic agents targeting these molecules utilize non-specific oxidative chemistry to achieve their effects (Source: StatPearls, Povidone Iodine, 2023). This mechanism typically involves the rapid oxidation of essential functional groups, such as thiols and amino acids, which results in the irreversible denaturation of proteins and the loss of membrane integrity in bacteria, fungi, and viruses (Source: CDC, Guideline for Disinfection and Sterilization, 2008). In addition to its antimicrobial properties, this oxidative approach targets inflammatory mediators in the local environment, such as TNF-alpha and various interleukins, effectively neutralizing them and reducing excessive inflammation in chronic wounds or skin infections (Source: Journal of Wound Care, 2019). Because the interaction is non-specific and hits multiple essential components simultaneously, it is highly effective against a wide spectrum of pathogens and carries a very low risk of developing antimicrobial resistance. However, the lack of specificity means these agents can also be cytotoxic to healthy host tissues, such as fibroblasts and keratinocytes, necessitating careful concentration control in clinical applications (Source: PubMed, Wound Repair and Regeneration, 2017).
Non-specific oxidation of functional groups such as sulfhydryl (thiol) groups, amino acids, and unsaturated fatty acids, leading to the denaturation of proteins, disruption of cell membranes, and inactivation of inflammatory signaling molecules.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Multiple microbial macromolecules and inflammatory mediators via non-specific oxidative chemistry.